GeneSurge, founded in 2019, is a research driven company that wants to improve the lives of individuals struck by certain diseases. With the focus on oncology, immunology and neurology a vast number of illnesses are analysed with the state-of-the-art techniques. While NGS and qPCR are commonly already in use, novel bioinformatic approaches are chosen to shed light in these highly complex maladies and are combined with analytical adjustments to better understand underlying biological principles. The goal is not only to ensure the best possible treatment for each patient, but also to allow monitoring of the health status to quickly act upon negative changes. Situated in Munich, GeneSurge has a substantial network to collaborate on these topics and to deliver tests that will enrich the life of each singular patient. GeneSurge is personalizing diagnostics!
Company Details
- Employees
- 1
- Founded
- 2019
- Address
- Munich, Bavaria 80333, De
- Industry
- Biotechnology
- Website
- http://www.genesurge.com
- Keywords
- AIMMS VU.
- HQ
- Munich, Bavaria
Genesurge Questions
Genesurge's website is http://www.genesurge.com
Genesurge's LinkedIn profile is https://de.linkedin.com/company/genesurge
Genesurge has
1 employees.
View email and phone details for 1
employees at Genesurge.
Genesurge's industry is
Biotechnology
Genesurge's top competitors are
Roycon,
Is-Diagnostics Ltd.,
Inscreenex Gmbh,
Daisybio,
Aimms Vu,
Qps Netherlands B.v.,
Inbiome,
Annogen,
Sciomics,
Lab42 Uva.
Genesurge's categories are Biotechnology
Genesurge's founding year is 2019
